Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis (Q28476684)

2

Robin Wood

0 references

Kenneth A. Freedberg

8

Kenneth A Freedberg

0 references

Xavier Anglaret

6

Xavier Anglaret

0 references

A. David Paltiel

4

A David Paltiel

0 references

Andrea Ciaranello

3

Andrea L Ciaranello

0 references

author name string

Sarah B Lorenzana

5

0 references

Adam W Stoler

Creative Commons Attribution 4.0 International

7

0 references

language of work or name

English

0 references

publication date

21 December 2010

0 references

published in

PLOS MEDICINE

0 references

volume

7

0 references

issue

12

0 references

page(s)

e1000382

0 references

copyright license

start time

21 December 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014084

Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014084

When to start antiretroviral therapy in resource-limited settings

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014084

Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014084

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014084

Efficacy of antiretroviral therapy in Africa: effect on immunological and virological outcome measures -- a meta-analysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014084

Scaling up antiretroviral therapy in South Africa: the impact of speed on survival

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014084

The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014084

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014084

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014084

Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire

29 September 2017

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000382

Healthy life expectancy in 191 countries, 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000382

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000382

Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000382

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000382

Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000382

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000382

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000382

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000382

Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000382

CD4 Decline and Incidence of Opportunistic Infections in Cape Town, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000382

Effect of Highly Active Antiretroviral Therapy on Time to Acquired Immunodeficiency Syndrome or Death using Marginal Structural Models

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000382

Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21209794

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PMED.1000382

1 reference

4972762

4972762

1 reference

1 reference

1 reference